Genentech settles dispute with MedImmune related to Cabilly patent
Genentech Inc. said late Wednesday it settled a dispute with MedImmune Inc. related to the Cabilly patent, which covers certain methods of producing antibodies.
Cellectricon AB and Fluxion Biosciences today announced that they have settled the patent infringement litigation that Cellectricon commenced against Fluxion in 2009.